Wells Fargo
RVMD icon

Wells Fargo’s Revolution Medicines RVMD Stock Holding History

Wells Fargo’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,400
Closed -$510K – 7422
2025
Q4 		$510K Hold
6,400
– – ﹤0.01% 4484
2025
Q3 		$299K Hold
6,400
– – ﹤0.01% 4688
2025
Q2 		$235K Buy
+6,400
New +$246K ﹤0.01% 4680

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wells Fargo's RVMD Position: Q1 2026 in Review

Wells Fargo increased its Revolution Medicines (RVMD) stake by 161% in Q1 2026, buying an estimated $2.13M and bringing the position to 34,241 shares worth $3.33M. The position accounts for ﹤0.01% of the portfolio, ranked #2905.

Wells Fargo first reported a position in RVMD in Q1 2020 and has held it in 25 quarters since. The position peaked at $3.86M in Q4 2024. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Wells Fargo held 34,241 shares of Revolution Medicines worth $3.33M as of Q1 2026.
  • Wells Fargo bought 21,121 Revolution Medicines shares in Q1 2026, an estimated $2.13M.
  • Revolution Medicines made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #2905 holding.
  • Wells Fargo first reported a position in Revolution Medicines in Q1 2020 and has held it in 25 quarters since.
  • Wells Fargo's Revolution Medicines position peaked at $3.86M in Q4 2024.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.